Nebkliq (Amlodipine Besilate, Nebivolol Hydrochloride)

Amlodipine besilate, the active ingredient in Nebkliq, is a calcium channel blocker presented as an oral tablet for oral use. It helps lower blood pressure in adults with hypertension and works together with nebivolol hydrochloride, a selective β1‑blocker that adds nitric‑oxide‑mediated vasodilation for complementary blood‑pressure control. The combination targets two complementary pathways to achieve consistent blood‑pressure reduction.

GNH USA supplies Nebkliq as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Nebkliq is indicated for hypertension, a condition characterized by elevated arterial pressure.

- Essential hypertension: reduces both systolic and diastolic blood pressure. - Isolated systolic hypertension: lowers high systolic readings while maintaining diastolic stability. - Diastolic hypertension: contributes to decreasing elevated diastolic pressure.

Nebkliq may cause a range of adverse reactions, varying from common to rare.

Common Side Effects: - Headache: mild to moderate intensity. - Peripheral edema: swelling of ankles or feet. - Dizziness or light‑headedness, especially after standing. - Flushing: transient warmth and redness of the skin. - Fatigue: general feeling of tiredness. - Palpitations: awareness of heartbeat.

Serious or Rare Side Effects: - Severe hypotension: marked drop in blood pressure leading to fainting. - Bradycardia: abnormally slow heart rate. - Heart block or atrioventricular conduction disturbances. - Angioedema: swelling of face, lips, tongue, or throat. - Significant liver enzyme elevation. - Allergic reactions: rash, itching, or anaphylaxis.

Before initiating Nebkliq, consider the following precautions.

- Blood pressure monitoring: regularly assess to avoid excessive hypotension. - Cardiac function evaluation: review history of heart failure or conduction disorders. - Concomitant beta‑blocker use: avoid additive effects that may cause bradycardia. - Hepatic impairment: adjust therapy if liver function is compromised. - Pregnancy and lactation: discuss risks with a healthcare professional before use. - Store at room temperature: keep in the original container, protect from moisture and direct sunlight.

Nebkliq can interact with several medicines; categorize them as follows.

Major Interactions (Avoid): - Strong CYP3A4 inhibitors (e.g., ketoconazole, clarithromycin): may increase plasma levels. - Other antihypertensives (e.g., ACE inhibitors, diuretics): risk of additive hypotension. - Non‑dihydropyridine calcium channel blockers (e.g., verapamil, diltiazem): can cause severe bradycardia.

Moderate Interactions (Monitor Closely): - CYP3A4 inducers (e.g., rifampicin, carbamazepine): may reduce efficacy. - NSAIDs: may blunt antihypertensive effect. - Antidiabetic agents: monitor blood glucose as blood pressure changes can affect glycemic control.